This work comprehensively describes etiological factors in the development , Progression and metastasis of human cancers, both for hematological malignancies and for solid Tumors.

Table of Contents

• Preface to the Fourth Edition
• Preface to the Third Edition
• Preface to the Second Edition
• Preface to the First Edition
• Editors and Contributors
• A
• AAMP
• AAV
• ABC Drug-Transporters
• ABCC Transporters
• ABC-Transporters
• Abraxas
• Abscopal Effects
• ABVD
• Achneiform Rash
• Actinic Keratosis
• Activated Natural Killer Cells
• Activation-Induced Cytidine Deaminase
• Active Specific Immunization
• Activin
• Activin Receptors
• Acute Lymphoblastic Leukemia
• Acute Megakaryoblastic Leukemia
• Acute Myeloid Leukemia
• Acute Promyelocytic Leukemia
• ADAM Molecules
• ADAM17
• Adaptive Immunity
• Adaptor Proteins
• Adducts to DNA
• Adenocarcinoma
• Adenoma
• Adenopathy
• Adenosine and Tumor Microenvironment
• Adenovirus
• Adherens Junctions
• Adhesion
• Adiponectin
• Adipose Tumors
• Adjuvant Chemoendocrine Therapy
• Adjuvant Therapy
• ADMET Screen
• Adoptive Immunotherapy
• Adoptive T-Cell Transfer
• Adrenocortical Cancer
• Adrenomedullin
• Adriamycin
• Adult Stem Cells
• Adult T-Cell Leukemia
• Aflatoxins
• Aflibercept
• Aggressive Fibromatosis in Children
• Aging
• Aging-Associated Inflammation
• AIDS-Associated Malignancies
• Akt Signal Transduction Pathway
• Alcohol Consumption
• Alcoholic Beverages Cancer Epidemiology
• Alcoholic Pancreatitis
• Aldehyde Dehydrogenases
• ALK Protein
• Alkylating Agents
• Allele Imbalance
• Allergy
• Allogeneic Cell Therapy
• Alpha-Fetoprotein
• Alpha-Fetoprotein Diagnostics
• Alu Elements
• AME Transcription Factor
• Amine Oxidases
• Amphiregulin
• Amplification
• Amplified in Breast Cancer 1
• Amrubicin
• Anaplastic Large Cell Lymphoma
• Anaplastic Lymphoma Kinase
• Anchorage-Independent
• Androgen Ablation Therapy
• Androgen Receptor
• Androgen-Independent Prostate Cancer (AIPC)
• Aneuploidy
• Angiogenesis
• Angiogenin
• Angiopoietins
• Angiotensin II Signaling
• Anoikis
• Anoxia
• Ansamycin Class of Natural Product Hsp90 Inhibitors
• Anthracyclines
• Antiangiogenesis
• Antibody-Dependent Cellular Cytotoxicity
• Antibody-Directed Enzyme Prodrug Therapy
• Anti-Cancer Peptides
• Antiglycolytics and Cancer
• Anti-Her2/Neu Peptide Mimetic
• Antihormonal Therapy
• Antihormones
• Anti-inflammatory Drugs
• Antimitotic Drugs
• Antioxidant Enzymes
• Antisense DNA Therapy
• Antiviral Defenses
• Antizyme Inhibitor
• AP-1
• APAF-1 Signaling
• APC Gene in Familial Adenomatous Polyposis
• APC/β-Catenin Pathway
• Apico-Basal Polarity
• Apoptosis
• Apoptosis Induction for Cancer Therapy
• Appendiceal Epithelial Neoplasms
• Aptamer Bioconjugates for Cancer Therapy
• Arachidonic Acid Pathway
• ARF Tumor Suppressor Protein
• Arginine
• Arginine-Depleting Enzyme Arginine Deiminase
• Aromatase and Its Inhibitors
• Aromatic Amine
• Array CGH
• Arrhenoblastoma
• Arsenic
• Artemisinin
• Aryl Hydrocarbon Receptor
• Arylamine N-Acetyltransferases
• Asbestos
• Ascites
• Askin Tumor
• Aspirin
• Astrocytoma
• Asymmetric Cell Division
• ATM Protein
• Aurora Kinases
• Autoantibodies
• Autocrine Signaling
• Autoimmunity and Cancer
• Autophagy
• Autotaxin
• 5-aza-2′ Deoxycytidine
• B
• Bacillus Calmette-Guérin
• BARD1
• Barrett Esophagus
• Basal Cell Carcinoma
• Basalioma
• B-Cell Lymphoma
• B-Cell Tumors
• Bcl2
• BCL3
• BCL6 Translocations in B-Cell Tumors
• BCR-ABL1
• Beckwith-Wiedemann Syndrome
• Beckwith-Wiedemann Syndrome Associated Childhood Tumors
• Behcet Disease
• Benign Prostate Hyperplasia
• Benzene and Leukemia
• Benzpyrene
• Beta-Glucosidase
• Betulinic Acid
• Bevacizumab
• Bid
• BIK Proapoptotic Protein
• Bile Acids
• Bile Duct Neoplasms
• Bin1
• Bioavailability
• Bioconjugate
• Bioluminescence Imaging
• Biomarkers in Detection of Cancer Risk Factors and in Chemoprevention
• Biomonitoring
• Birt-Hogg-Dubé Syndrome
• Bispecific Antibodies
• Bisphosphonates
• Bladder Cancer
• Bladder Cancer Molecular Therapy
• Bladder Cancer Pathology
• Blast Crisis
• Bleomycin
• Blood-Brain Barrier
• Bloom Syndrome
• Bone Loss Cancer Mediated
• Bone Metastasis
• Bone Tropism
• Bone Tumors
• BORIS
• Bortezomib
• Bovine Papillomavirus
• Bowen Disease
• Brachytherapy
• BRaf-Signaling
• BRAF Somatic Alterations
• Brain Cancer Pathology
• Brain Tumors
• BRCA1/BRCA2 Germline Mutations and Breast Cancer Risk
• Breast Cancer
• Breast Cancer Antiestrogen Resistance
• Breast Cancer Carcinogenesis
• Breast Cancer Drug Resistance
• Breast Cancer Epidemiology
• Breast Cancer Familial Risk
• Breast Cancer Immunotherapy
• Breast Cancer Multifocality
• Breast Cancer Multistep Development
• Breast Cancer New Therapies: HER2, VEGF, and PARP as Targets
• Breast Cancer Prognostic and Predictive Biomarkers
• Breast Cancer Prognostic Biomarkers
• Breast Cancer Stem Cells
• Breast Cancer Susceptibility Genes
• BRIT1 Gene
• BRMS1
• Bryostatin-1
• Burkitt Lymphoma
• Bystander Effect
• C
• Ca2+ Homeostasis
• Cachexia
• Cafe-Au-Lait Spots
• Cajal Bodies
• Calcitonin
• Calcium-Binding Proteins
• Calpain
• Calreticulin
• CAMTA1
• Cancer
• Cancer and Cadmium
• Cancer Causes and Control
• Cancer Epidemiology
• Cancer Epigenetics
• Cancer Germline Antigens
• Cancer Stem Cells Targeted Drug Development
• Cancer Stem-Like Cells
• Cancer Vaccines
• Cannabinoids
• Carbon Metabolism
• Carbonyl Metabolism
• Carcinoembryonic Antigen
• Carcinogen Metabolism
• Carcinogenesis
• Carcinoid
• Carcinoid Tumors
• Carcinoma In Situ
• Carcinomatosis
• Carcinosarcoma
• Cardiac Tumors
• Carney Complex
• Carotenoids
• Case Control Association Study
• Caspase
• Caspase-8
• Caspase-Independent Apoptosis
• Castrate-Resistant Prostate Cancer
• Castration-Resistant Prostate Cancer
• Cathepsin-D
• Cathepsins
• Caveolins
• CBP/p300 Coactivators
• CCCTC-Binding Factor
• CD Antigens
• CD26/DPPIV in Cancer Progression and Spread
• CD44
• CDCP1
• CDKN2A
• CDX2
• CEA Gene Family
• CEACAM1 Adhesion Molecule
• Celastrol
• Celecoxib
• Cell Adhesion Molecules
• Cell Biology
• Cell Cycle Checkpoint
• Centrosome
• Ceramide
• Cervical Cancers
• Cetuximab
• Chelators as Anti-Cancer Drugs
• Chemical Carcinogenesis
• Chemically Induced Cell Transformation
• Chemoattraction
• Chemokine Receptor CXCR4
• Chemokines
• Chemoprevention
• Chemoprotectants
• Chemoradiotherapy
• Chemosensibilization
• Chemotherapy
• CHFR
• Childhood Adrenocortical Carcinoma
• Childhood Cancer
• Childhood Cancer and Pediatric Cancer Predisposition Syndromes
• Childhood Cancer and Treatment-Related Toxicities
• Chimeric Antigen Receptor (CAR)
• Chimeric Antigen Receptor on T Cells
• Chinese Versus Western Medicine
• Cholangiocarcinoma
• Choline Kinase
• Chorioallantoic Membrane
• Chromatin Remodeling
• Chromium Carcinogenesis
• Chromophore-Assisted Laser Inactivation
• Chromosomal Fluorescence In Situ Hybridization
• Chromosomal Instability
• Chromosomal Translocation t(8;21)
• Chromosomal Translocations
• Chronic Lymphocytic Leukemia
• Chronic Myeloid Leukemia
• Chronic Obstructive Pulmonary Disease and Lung Cancer
• Cip-Interacting Zinc Finger Protein 1 Ciz1
• Circadian Clock Induction
• Circulating Nucleic Acids
• Circulating Tumor Cells
• Cisplatin
• CK2
• Cladribine
• Class II Tumor Suppressor Genes
• Clinical Cancer Biomarkers
• Clinical Trial
• Clusterin
• Coagulopathy
• Coffee Consumption
• Cohesins
• Cohort Study
• Colon Cancer Carcinogenesis in Human and in Experimental Animal Models
• Colon Cancer Classification
• Colon Cancer Genomic Pathways
• Colon Cancer Molecular and Targeted Experimental Therapy
• Colon Cancer Pathology of Hereditary Forms
• Colorectal Cancer
• Colorectal Cancer Chemoprevention
• Colorectal Cancer Clinical Oncology
• Colorectal Cancer Nutritional Carcinogenesis
• Colorectal Cancer Pathology
• Colorectal Cancer Premalignant Lesions
• Colorectal Cancer Therapeutic Antibodies
• Colorectal Cancer Vaccine Therapy
• Combinatorial Cancer Therapy
• Combinatorial Selection Methods
• Comet Assay
• Comparative Oncology
• Complement-Dependent Cytotoxicity
• Confocal Laser-Scanning Microscopy In Vivo
• Conjugated Linolenic Acids
• Connexins
• Constitutive Androstane Receptor
• Contact Normalization
• Contralateral Breast Cancer
• Convection-Enhanced Delivery
• Cortactin
• Cowden Syndrome
• COX-2 in Colorectal Cancer
• CpG Islands
• Cripto-1
• Crohn Colitis
• Crohn Disease
• Cryosurgery
• Cryptotanshinone
• Crypts
• Cucurbitacin B
• Cullin Ubiquitin E3 Ligases
• Curcumin
• Cushing Syndrome
• Cutaneous Desmoplastic Melanoma
• Cyclin D
• Cyclin G-Associated Kinase
• Cyclin-Dependent Kinases
• Cyclins
• Cyclooxygenase
• Cyclophosphamide
• Cylindromatosis
• Cystatins
• Cystic Fibrosis
• Cystic Nephroma
• Cytochalasin B
• Cytochrome P450
• Cytokine
• Cytokine Receptor as the Target for Immunotherapy and Immunotoxin Therapy
• Cytoskeleton
• Cytotoxic T Cells
• D
• Dactinomycin
• Daxx
• Death Receptors
• Decatenation G2 Checkpoint
• Decay-Accelerating Factor
• Decoy Receptor
• Decoy Receptor 3
• Deferasirox
• Deleted in Malignant Brain Tumors 1
• Deleted in Pancreatic Carcinoma Locus 4
• Dendritic Cells
• Dental Pulp Neoplasms
• Desmoglein-2
• Desmoid Tumor
• Desmoplasia
• Desmoplastic Small Round Cell Tumor
• Desmosomes
• Detoxification
• Diabody
• Diethylstilbestrol
• Diffuse Large B-Cell Lymphoma
• Dimethylfumarate
• Dioxin
• DLC1
• DNA Damage
• DNA Damage Response
• DNA Damage Response Genes
• DNA Damage Tolerance
• DNA Damage-Induced Apoptosis
• DNA Oxidation Damage
• DNA Vaccination
• Docetaxel
• Dormancy
• Doublecortin
• Drug Delivery Systems for Cancer Treatment
• Drug Design
• Drug Discovery
• Drug Resistance
• Ductal Carcinoma In Situ
• Duffy Antigen Receptor for Chemokines
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging
• Dysplasia
• E
• E T V6
• E2A-PBX1
• Early B-Cell Factors
• Early Genes of Human Papillomaviruses
• Early-Stage Ovarian Cancer
• E-Box
• E-Cadherin
• Efferocytosis
• Eicosanoids
• Electromagnetic Fields
• Electroporation
• ELISA
• Elongin BC Complex
• Embryonic Stem Cells
• Endocan
• Endocrine Oncology
• Endocrine Therapy
• Endocrine Therapy in Breast Cancer
• Endocrine-Related Cancers
• Endocytosis
• Endometrial Cancer
• Endometrioma
• Endoplasmic Reticulum Stress
• Endosomal Compartments
• Endostatin
• Endothelial-Derived Gene-1
• Endothelins
• EpCAM
• Eph Receptors
• Epidemiology of Cancer
• Epidermal Growth Factor Inhibitors
• Epidermal Growth Factor Receptor
• Epidermal Growth Factor-like Ligands
• Epigallocatechin
• Epigenetic
• Epigenetic Biomarker
• Epigenetic Gene Silencing
• Epigenetic Modifications
• Epigenetic Therapy
• Epigenomics
• Epithelial Tumorigenesis
• Epithelial-to-Mesenchymal Transition
• Epithelium
• Epothilone B Analogue
• Epothilones
• Epstein-Barr Virus
• Epstein–Barr Virus Latent Membrane Protein 1
• Erlotinib
• ERM Proteins
• Erythroleukemia
• Erythropoietin
• E-Selectin-Mediated Adhesion and Extravasation in Cancer
• Esophageal Adenocarcinoma
• Esophageal Cancer
• Estradiol
• Estrogen Receptor
• Estrogen Signaling
• Estrogenic Hormones
• Ether à-go-go Potassium Channels
• Etidronate
• Etoposide
• Ets Transcription Factors
• Everolimus
• Ewing Sarcoma
• EWS-FLI (ets) Fusion Transcripts
• Exfoliation of Cells
• Exosomal miRNA
• Exosome
• Extracellular Matrix Remodeling
• Extracellular Signal-Regulated Kinases 1 and 2
• Extrapulmonary Small Cell Cancer
• F
• Fanconi Anemia
• Farnesylation
• Fatty Acid Transport
• FDG-PET
• Fecal Immunochemical Test
• Fecal Occult Blood Test
• Fenretinide
• Ferroptosis
• Fever of Unknown Origin
• Fibrinogen
• Fibroblast Growth Factors
• Fibronectin
• Fibrosarcoma
• Fibrosis and Cancer
• Fibulins
• Fine Needle Aspiration Biopsy
• Firestorm Pattern
• Flavonoids
• FLICE-Inhibitory Protein
• Flow Cytometry
• FLT3
• Fludarabine
• Fluorescence Diagnostics
• Fluorescence in Situ Hybridization
• Fluorouracil
• Fluoxetine
• Focal Adhesion Kinase
• Follicular Lymphoma
• Follicular Thyroid Tumors
• Follistatin
• Food-Borne Carcinogens
• Forkhead Box M1
• Fragile Histidine Triad
• Fragile Sites
• Fucosylation
• α1-6 Fucosyltransferase
• Fucoxanthin
• Fulvestrant
• Fumarate Hydratase
• Funnel Factors
• Furin
• Fusion Genes
• G
• G Proteins
• G2/M Transition
• GAGE Proteins
• Gain-of-Function p53
• Gallbladder Cancer
• Gangliosides
• Gankyrin
• Gap Junctions
• Gastric Cancer
• Gastric Cancer Therapy
• Gastrin
• Gastrinoma
• Gastrin-Releasing Peptide
• Gastrointestinal Stromal Tumor
• Gefitinib
• Gelsolin
• Gemcitabine
• Gene Therapy
• Genetic Toxicology
• Genistein
• Genomic Imbalance
• Genomic Imprinting
• Genomic Instability
• Germinoma
• Giant Cell Tumor
• Ginkgo biloba
• Gleason Grading
• GLI Proteins
• Glioblastoma Therapy
• Glucose Metabolism
• Glutathione Conjugate Transporter RLIP76
• Glutathione S-Transferase
• Glycobiology and Cancer
• Glycosylation
• Gonadotropin-Releasing Hormone
• Good Laboratory Practices
• Good Manufacturing Practices
• Grading of Tumors
• Graft Acceptance and Rejection
• Granulosa Cell Tumors
• Grape Seed Extract
• Graves Disease
• Green Tea Cancer Prevention
• Growth Hormone-Releasing Hormone
• GTPase
• Gut Microbiota
• Gut Peptides
• Gynecomastia
• H
• γH2AX
• Hairy Cell Leukemia
• Hamartin
• Haploinsufficiency
• HB-EGF
• HDAC Inhibitors
• Head and Neck Cancer
• Hedgehog Signaling
• Helicobacter Pylori in the Pathogenesis of Gastric Cancer
• Hematological Malignancies, Leukemias, and Lymphomas
• Heparanase
• Heparanase Inhibitors
• Hepatic Epithelioid Hemangioendothelioma
• Hepatic Ethanol Metabolism
• Hepatitis B Virus
• Hepatitis B Virus x Antigen-Associated Hepatocellular Carcinoma
• Hepatitis C Virus
• Hepatoblastoma
• Hepatocellular Carcinoma
• Hepatocellular Carcinoma Molecular Biology
• Hepatocellular Carcinoma: Etiology, Risk Factors, and Prevention
• HER-2/neu
• Herceptin
• Herpesvirus-Associated Ubiquitin-Specific Protease De-ubiquitinase
• Heterochromatin
• Heterocyclic Amines
• Hexavalent Chromium
• Hexokinase 2
• Histocompatibility
• Histocompatibility Antigens
• Histone Acetyltransferases
• Histone Modification
• HLA Class I
• Hodgkin and Reed/Sternberg Cell
• Hodgkin Disease
• Hodgkin Lymphoma, Clinical Oncology
• Hollow Fiber Assay
• Homeobox Genes
• Homing Peptides and Vascular Zip Codes
• Homologous Recombination Repair
• Hormonal Carcinogenesis
• Hormonal Therapy
• Hormone Replacement Therapy
• Hormone-Refractory Prostate Cancer
• Hormones
• HRAS
• HSNF5/INI1/SMARCB1 Tumor Suppressor Gene
• Hsp90
• HSV-TK-/Ganciclovir-Mediated Toxicity
• Human Herpesvirus 6
• Human Papillomaviruses in Head and Neck Cancer
• Human T-Lymphotropic Virus
• Huntingtin Interacting Protein 1
• HuR
• Hurthle Cell Adenoma and Carcinoma
• Hyaluronan Synthases
• Hyaluronidase
• Hydrogen Peroxide
• 2-Hydroxyoleic Acid
• Hypericin
• Hyperplasia
• Hyperthermia
• Hypomethylation of DNA
• Hypoxia
• Hypoxia-Inducible Factor-1
• I
• IA4
• IAP-3
• IARC TP53 Database
• ICF Syndrome
• ICL670A
• Idiopathic Myelofibrosis
• Idiotype Vaccination
• Idiotypic Vaccination
• IDO
• I-FLICE
• iFOBT
• IgE-Mediated Hypersensitivity
• IHC
• IL-6
• ILP1
• Imatinib
• Imatinib (Gleevec)
• Imatinib Mesylate
• Imidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3, 4-dihydro-3-methyl-4-oxo-
• Immediate Early Stress Response
• Immune Escape
• Immune Responses to Autoantigens
• Immune-Mediated Suppression
• Immunochemical Fecal Occult Blood Test
• Immunocytochemistry
• Immunoediting
• Immunoglobulin Rearrangements
• Immunohistochemistry
• Immunohistology
• Immunoliposomes
• Immunological Fecal Occult Blood Test
• Immunophenotypic Determinants
• Immunoprevention
• Immunoprophylaxis of Cancer
• Immunoproteasome
• Immunoreceptor
• Immunosuppression and Cancer
• Immunosurveillance of Tumors
• Immunotherapy
• Immunotoxins
• Imprinting
• In Situ Breast Cancer
• In Situ Cancer
• In Situ Carcinoma
• In Utero Exposure to Carcinogenic Agents
• In Vitro Bystander Effect
• In Vitro Genetics
• In Vivo Bystander Effect
• Indirect Effect
• Indirubin and Indirubin Derivatives
• Individualized Treatment
• Indoleamine 2,3-Dioxygenase
• Induced Pluripotent Stem Cells
• Induction Chemotherapy
• Infiltration
• Inflammation
• Inflammatory Bowel Disease (also includes Ulcerative Colitis)-Related Cancer
• Inflammatory Bowel Disease-Associated Cancer
• Inflammatory Breast Cancer
• Inflammatory Response and Immunity
• Inflammosome
• Infusion of T Cells
• INHBA
• INHBB
• INHBC
• INHBE
• Inherited Human Polycystic Kidney Disease
• Inhibin-β Chain
• Inhibitor of FLICE
• INK4A
• Innate Immunity
• Inositol Lipids
• Insulin Receptor
• Insulin Signaling
• Insulin-Like Growth Factor (IGF) Signaling
• Insulin-Like Growth Factors
• Insulinoma
• Integrated Positron Emission Tomography/Computed Tomography
• Integrin Signaling
• Integrin-Mediated Death
• Interferon-Alpha
• Interleukin-17
• Interleukin-4
• Interleukin-6
• Intermediate Endpoint
• Intermediate Junction
• Intermediately or Poorly Differentiated Lymphocytic Lymphoma
• Internalization
• Interphase Cytogenetics
• Intersectin
• Interstitial Microinfusion
• Intestinal Alkaline Phosphatase
• Intestinal Metaplasia
• Intestinal Organoids
• Intestinal Sphere
• Intracerebral Clysis
• Intracerebral Microinfusion
• Intraductal Carcinoma
• Intraductal Papillary Mucinous Tumor
• Intraocular Melanoma
• Intrinsically Disordered Proteins
• Intrinsically Unfolded Proteins
• Intrinsically Unstructured Proteins
• 3D In Vitro Culture
• Invadosome
• Invasion
• Ion Channels
• Ionizing Radiation (IR)-Induced Protein-8 (XIP-8)
• Ionizing Radiation Therapy
• Ionizing Radiation-Induced Cancer
• IPL1
• iPS Cells
• iPSCs
• IQ Motif-Containing GTPase-Activating Protein
• IQGAP1 Protein
• Irinotecan
• Iron-Regulated Necrosis
• Islet Cell Tumor
• Islet Cell Tumors
• Islet Cell Tumors (Pancreatic NET)
• Isoflavones
• (-)-1-Isothiocyanato-4(R)-(methylsulfinyl) Butane
• Ixabepilone
• J
• J1 220/200
• JAB1
• Japanese Silver Apricot
• Jasmonates in Cancer Therapy
• Jelly Belly
• JFY1
• JmjC Domain-Containing Protein 3
• JMJD3
• JNK Subfamily
• JNK1
• JNK2
• JNK3
• Jumonji Domain-Containing Protein 3
• Juvenile Type
• K
• Kallikreins
• Kaplan-Meier Survival Analysis
• Kaposi Sarcoma
• KDM6
• Kinetochore–Microtubule Interactions
• KISS1
• Kit/Stem Cell Factor Receptor in Oncogenesis
• Klatskin Tumors
• Klotho Tumor Suppressor
• Knudson Hypothesis
• Koch's Postulates
• KRAS
• KRAS in Colorectal Cancer Therapy
• KSP Mitotic Spindle Motor Protein
• Kupffer Cells
• L
• Lactoferricin Antiangiogenesis Inhibitor
• Laminin Signaling
• Langerhans Cell Histiocytosis
• Large Cell Neuroendocrine Carcinoma
• Laryngeal Carcinoma
• Latency-Associated Nuclear Antigen (LANA)
• Lats in Organ Size Regulation and Cancer
• Lead Exposure
• Lead Optimization
• Leiomyosarcoma
• Lentiviral Vectors
• Leptomeningeal Dissemination
• Leukemia Inhibitory Factor
• Leukemia Stem Cells
• Leukotrienes
• Lewis Antigens
• Leydig Cell Tumor
• Li-Fraumeni Syndrome
• LINE-1 Elements
• Linkage Disequilibrium
• Linoleic Acid
• Lipid Mediators
• Lipid Peroxidation
• Lipid Raft
• Lipocalin
• Lipoma-Preferred Partner
• Liposomal Chemotherapy
• 5-Lipoxygenase
• Live Cell Imaging
• Lobular Involution of the Breast
• Locoregional Therapy
• Log-Kill Hypothesis
• LPA
• Luciferase Reporter Gene Assays
• Lugol-Unstained Lesion
• Lunasin
• Lung Cancer
• Lung Cancer and Smoking Behavior
• Lung Cancer Clinical Oncology
• Lung Cancer Epidemiology
• Lung Cancer Pharmacogenomics
• Lung Cancer Staging
• Lung Cancer Targeted Therapy
• Lymphadenectomy
• Lymphangiogenesis
• Lymphatic Vessels
• Lynch Syndrome
• Lysophosphatidylcholine
• M
• Macrophages
• Macrophage-Stimulating Protein
• MAGE-A11
• Maintenance Chemotherapy
• Major Vault Protein
• Male Breast Cancer
• Malignancy-Associated Changes
• Malignant Lymphoma: Hallmarks and Concepts
• MALT Lymphoma
• Mammalian Target of Rapamycin
• MammaPrint Test
• Mammographic Breast Density and Cancer Risk
• Mammographic Density
• Mantle Cell Lymphoma
• MAP Kinase
• Marginal Zone B-Cell Lymphoma
• Maspin
• Mast Cells
• Mastocytosis
• Matrix Metalloproteinases
• Mcl Family
• Mcl-1
• MCT-1 Oncogene
• MDM Genes
• MDM2
• Medullary Thyroid Cancer Targeted Therapy
• Melanocytic Tumors
• Melanoma Antigens
• Melanoma Drug Treatment
• Melanoma Vaccines
• Melanoma-Associated Retinopathy
• Melatonin
• Membrane Transporters
• Membrane-Linked Docking Protein
• Membrane-Lipid Therapy
• Menopausal Symptoms After Breast Cancer Therapy
• Merlin
• Mesenchymal Stem Cells
• Mesoblastic Nephroma
• Mesothelin
• Mesothelioma
• MET
• Meta-Analysis
• Metabolic Polymorphisms and Cancer Susceptibility
• Metabolic Reprogramming
• Metal Drugs
• Metastasis
• Metastasis Suppressor Gene
• Metastasis Suppressor KAI1/CD82
• Metastatic Breast Cancer Experimental Therapeutics
• Metastatic Colonization
• Methoxyestradiol
• Methylation
• Methylation-Controlled J Protein
• Methyltransferases
• Metronomic Chemotherapy
• MIC Molecules
• MIC-1
• Microarray (cDNA) Technology
• Microcell-Mediated Chromosome Transfer
• Microcystin-LR
• Micrometastasis
• Micronucleus Assay
• MicroRNA
• Microsatellite Instability
• Microtubule-Associated Proteins
• Migration
• Mineral Nutrients
• Minimal Residual Disease
• Minodronate
• Mismatch Repair in Genetic Instability
• Mitochondrial DNA
• Mitochondrial Membrane Permeabilization in Apoptosis
• Mitogen-Activated Protein Kinase Kinase Kinases
• Mitogen-Inducible Gene 6 in Cancer
• Mitomycin C
• Mitotic Arrest-Deficient Protein 1
• Mitotic Catastrophe
• Modifier Loci
• Modular Transporters
• Molecular Chaperones
• Molecular Imaging
• Molecular Pathology
• Molecular Therapy
• Monoclonal Antibodies for Cancer Therapy
• Monoclonal Gammopathy of Undetermined Significance (MGUS)
• Motility
• Mouse Models
• mRNA Translation
• Mucins
• Mucoepidermoid Cancer
• Multigene Array
• Multiple Endocrine Neoplasia Type 1
• Multiple Myeloma
• Multistep Development
• Mutagen Sensitivity
• Mutation Rate
• Mutator Phenotype
• MUTYH-Associated Colorectal Polyposis
• MYB
• MYC Oncogene
• Myeloablative Megatherapy
• Myelodysplastic Syndromes
• Myelosuppression
• Myopodin
• Myxoid Liposarcoma
• N
• N-(4-hydroxyphenyl)retinamide
• NA1/NA2
• NAALADase
• NAB
• NaCHOleate
• NAD-Dependent Deacetylase Sirtuin-1
• Naevoid Basal Cell Carcinoma Syndrome
• NAG-1
• NAME
• Nanocapsules
• Nanoformulations
• Nanomedicine
• Nanoparticles
• Nanoparticles in Cancer Therapy
• Nanoparticles in Diagnosis and Treatment
• Nanospheres
• Nanotechnology
• Nasopharyngeal Carcinoma
• NAT
• Natural Immunity
• Natural Killer Cell Activation
• Natural Killer Group 2D
• Natural Products
• Natural Yellow 3
• Naturally Disordered Proteins
• Naturally Unfolded Proteins
• Naturally Unstructured Proteins
• NBCCS
• NBK (Natural Born Killer)
• NCA-160
• NCI60_003316
• NCoA3
• ncRNA
• Necroptosis
• Necrosis
• Needle Aspiration Biopsy
• Needle Biopsy
• Nek2
• Nemosis
• Neoadjuvant Chemotherapy (Neoadjuvant Therapy)
• Neoadjuvant Therapy
• Neoplastic Meningitis
• Neovascularization
• Nephroblastoma
• Nestin
• NET
• Neuroblastoma
• Neurocytoma
• Neuroectodermal Tumor
• Neuroendocrine Carcinoma
• Neuroendocrine Neoplasms
• Neuroendocrine Tumors of the Pancreas
• Neuroepithelioma
• Neurofibromatosis 1
• Neurofibromatosis 2
• Neurokinins
• Neuromedin
• Neuronectin
• Neuron-Restrictive Silencer Factor (NRSF)
• Neuro-oncology: Primary CNS Tumors
• Neuropathy
• Neuropeptides
• Neuropilin Ligands
• Neuroprotection
• Neurotrophic Factors
• Neurotrophins
• Neutropenia
• Neutrophil Elastase
• Neutrophil Elastase 2
• Neutrophil Expressed (ELANE as the official gene symbol)
• Nevi
• Nevocellular Nevus
• Nevus
• New York Esophageal Squamous Cell Carcinoma 1
• Nexavar
• NF1
• NF2
• NF2 Gene Product
• NF-κB
• NGF Family
• NGRD2
• Nickel Carcinogenesis
• Nickel Tumorigenesis
• Nickel-Induced Cell Transformation
• Nicotine Addiction
• Nicotine Dependence
• Nijmegen Breakage Syndrome
• Nilotinib
• Nitric Oxide
• Nitrogen-Containing Bisphosphonate
• NK Cell Induction
• NK Cell Stimulation
• NKG2D
• NKG2D Receptor
• N-myc Downstream-Regulated Gene
• N-myc Downstream-Regulated Gene, NDRG1
• Nodularin
• Nonclassical Apoptosis
• Noncoding RNA
• Noninvasive breast Cancer
• Nonprimary APC Mutation Colorectal Cancer
• Non-Rhabdomyosarcoma Soft Tissue Sarcomas
• Non-Seminomatous Germ Cell Tumor
• Non-Small-Cell Lung Cancer
• Nonspecific Cross-Reacting Antigen with a Mw of 160kD
• Nonsteroidal Anti-inflammatory Drugs
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Nontargeted Effect
• Non-Targeted Effects
• Nonviral Vector for Cancer Therapy
• Norton-Simon Hypothesis
• Notch/Jagged Signaling
• NPC
• NPP2
• NR1C
• NR1I3
• NR3C4
• NRSTS
• NS3
• NSC-10514-F
• NSC-312887
• NSC362856
• NSC-638850
• NSC-684766
• NSC-710428
• Nuclear Factor-KappaB
• Nuclear Factor-κB
• Nuclear Receptor Coactivator 3
• Nuclear Receptor Subfamily 1, Group I, Member 2 (NR1I2)
• Nuclear Receptors
• Nucleic Acid-Based Biomarkers
• Nucleolin
• Nucleoporin
• Nucleosome Remodeling
• Nucleotide Excision Repair
• NUP98-HOXA9 Fusion
• NUPR1
• Nutraceuticals
• Nutrition Status
• Nutritional Factors
• Nutritional Prevention of Colon Cancer
• NY ESO 1
• NY-ESO-1
• O
• Obesity and Cancer Risk
• Okadaic Acid
• Oligoastrocytomas
• Oligodendroglioma
• Omental Immune Aggregates
• OncoArray
• Oncofetal Antigen
• Oncogene
• Oncogene Addiction
• Oncology Models in Mice
• Oncolytic Adenovirus
• Oncolytic Virus
• Oncopeptidomics
• Oncoplastic Surgery
• Oncostatin M
• Oncotype DX
• Optimal Treatment for Women with Ovarian Cancer
• Oral Cancer
• Orphan Nuclear Receptors
• Osteoblastic Bone Lesion
• Osteochondroma
• Osteoclast
• Osteolysis
• Osteopontin
• Osteoporosis
• Osteosarcoma
• Ovarian Cancer
• Ovarian Cancer Chemoresistance
• Ovarian Cancer Chemotherapy
• Ovarian Cancer Clinical Oncology
• Ovarian Cancer Drug Resistance
• Ovarian Cancer Epidemiology
• Ovarian Cancer Hormonal Therapy
• Ovarian Cancer Immunotherapy
• Ovarian Cancer Pathology
• Ovarian Cancer Stem Cells
• Ovarian Germ Cell Tumors
• Ovarian Mucinous Carcinoma
• Ovarian Serous Carcinoma
• Ovarian Small Cell Carcinoma Hypercalcemic Type
• Ovarian Stromal and Germ Cell Tumors
• Ovarian Tumors During Childhood and Adolescence
• Oxidative Stress
• Oxygen Sensing
• Oxygenation of Tumors
• P
• p21
• p27
• p53 Family
• P8 Protein
• Paclitaxel
• Palladium-Based Anti-Cancer Therapeutics
• Palliative Therapy
• Pancreatic Cancer
• Pancreatic Cancer Basic and Clinical Parameters
• Pancreatic Cancer Biology and Management
• Pancreatic Cancer Biomarkers
• Pancreatic Cancer Desmoplastic Reaction and Metastasis
• Pancreatic Cancer Development and Regeneration
• Pancreatic Cancer Metastasis
• Pancreatic Cancer Pathogenesis
• Pancreatic Cancer Stem Cells
• Pancreatic Cancer Molecular Targets for Therapy
• Pancreatitis
• Pannexins
• Papanicolaou Test
• Papillary Thyroid Carcinoma
• PARAHOX
• Parathyroid Hormone-Related Protein
• PARP Inhibitors
• Particle-Induced Cancer
• Pathology
• Paxillin
• PCA3
• PDT-Induced Apoptosis
• Pediatric Brain Tumors
• Pediatric HIV/AIDS
• Pemetrexed
• Pentakisphosphate
• Peptide Biomarkers
• Peptide Vaccines for Cancer
• Peptidylarginine Deiminase Enzymes
• Periostin
• Peripheral Neuropathy
• Peroxisome Proliferator-Activated Receptor
• Personalized Cancer Medicine
• Peutz–Jeghers Syndrome
• P-Glycoprotein
• Phage Display
• Pharmacogenomics in Multidrug Resistance
• Pharmacokinetics and Pharmacodynamics in Drug Development
• Pharmacophore
• Phase II Enzymes
• Pheochromocytoma
• Phosphatase
• Phospholipase A2
• Phospholipase D
• Photocarcinogenesis
• Photochemoprevention
• Photodynamic Therapy
• Photo-Induced DNA Damage
• Photothermal Therapy
• Phytochemicals in Cancer Prevention
• Phytoestrogens
• PI3K Signaling
• PICALM
• PIK3CA
• PIM Protein Kinase Family
• Placenta Growth Factor
• Placental Site Trophoblastic Tumor
• Plasmacytoma
• Plasminogen-Activating System
• Platelet
• Platelet-Activating-Factor
• Platelet-Derived Growth Factor
• Platinum Complexes
• Platinum-Refractory Testicular Germ Cell Tumors
• Pleiotrophin
• Pleural Effusion
• Plexins
• Podoplanin
• POEMS Syndrome
• Poly(ADP-Ribosyl)ation
• Polyamines
• Polycomb Group
• Polycyclic Aromatic Hydrocarbons
• Polycystic Kidney Disease
• Polycythemia
• Polyphenols
• Polyunsaturated Fatty Acids
• Positron Emission Tomography
• Preclinical Testing
• Pre-mRNA Splicing
• Preneoplastic Lesions
• Presenilin
• Primary Myelofibrosis
• Probiotics and Cancer
• Progestin
• Programmed Cell Death 4
• Progression
• Prolactin
• Prostaglandins
• Prostate Cancer
• Prostate Cancer Chemotherapy
• Prostate Cancer Clinical Oncology
• Prostate Cancer Diagnosis
• Prostate Cancer Epidemiology
• Prostate Cancer Experimental Therapeutics
• Prostate Cancer Genetic Toxicology
• Prostate Cancer Hormonal Therapy
• Prostate Cancer Molecularly Targeted Therapies
• Prostate Cancer Prevention
• Prostate Cancer Radionuclide Imaging
• Prostate Cancer Radionuclide Therapy
• Prostate Cancer Stem Cells
• Prostate Cancer Targeted Therapy
• Prostate-Specific Antigen
• Prostate-Specific Membrane Antigen
• Protease-Activated Receptor Family
• Protease-Activated Receptors
• Proteasome
• Proteasome Inhibitors
• Protein Kinase C Family
• Protein Kinases
• Proteinase-Activated Receptor-1
• Proteinase-Activated Receptor-2
• Proteinase-Activated Receptor-3
• Proteinase-Activated Receptor-4
• Proteinchip
• 14-3-3 Proteins
• Proteomics
• Proton Beam Therapy
• Prune
• Pseudomyxoma Peritonei
• PUMA
• Pyroptosis
• Q
• Quantitative Structure Activity Relationship
• R
• Radiation Carcinogenesis
• Radiation Oncology
• Radiation Sensitivity
• Radiation-Induced Sarcomas After Radiotherapy
• Radioimmunotherapy
• Radiological Response Criteria
• Radioprotectors
• Radiosensitization
• Radiosensitizer
• Radon
• Raf Kinase
• RANK–RANKL Signaling
• Rap1 and Sipa-1
• Rapamycin
• RAS Activation
• RAS-Association Domain Family 1
• RAS Genes
• RAS Transformation Targets
• RE1-Silencing Transcription Factor
• Reactive Oxygen Species
• Receptor Cross-Talk
• Receptor Tyrosine Kinase Inhibitors
• Receptor Tyrosine Kinases
• Receptors
• RECK Glycoprotein
• Recombinant Therapeutics
• Rectal Cancer
• Reductases
• Regeneration
• Regorafenib
• Regulatory T Cells
• Rel
• Relaxin
• Renal Cancer Clinical Oncology
• Renal Cancer Diagnosis
• Renal Cancer Genetic Syndromes
• Renal Cancer Molecular Therapy
• Renal Cancer Pathogenesis
• Renal Cancer Targeted Therapies with Tyrosine Kinase Inhibitors
• Renal Cancer Therapy
• Renal Cancer Treatment
• Renal Cancer Trends in Molecularly Targeted Therapies
• Repair of DNA
• Replication Factories and Replication Foci
• Resistin
• Restriction Landmark Genomic Scanning
• Resveratrol
• RET
• Retinoblastoma
• Retinoblastoma Protein, Biological and Clinical Functions
• Retinoblastoma Protein, Cellular Biochemistry
• Retinoic Acid
• Retinoid Receptor Cross-Talk
• Retinoids
• Retroviral Insertional Mutagenesis
• Rhabdoid Tumor
• Rhabdomyosarcoma
• Rho Family Proteins
• Ribosome-Inactivating Proteins
• Rituximab
• RNA Interference
• RNA Polymerase I Transcription
• Ron Receptor
• Runx1
• S
• S(1–5), T16, EFEMP1, FBLN-3
• S-100 Proteins
• SAAB
• SAC
• SAHA
• Salicylate
• Salisburia adiantifolia
• Salisburia macrophylla
• Salivary agglutinin (SAG, Human)
• Salivary Gland Malignancies
• Salt Intake
• Salting
• SAPKα
• SAPKβ
• SAPKγ
• Saporin
• Scaffold Proteins
• Scatter Factor
• SCF Receptor
• SCF-R
• SCGE
• SCH52365
• Schwannoma-Derived Growth Factor
• Schwannomin
• Scirrhous
• Sclerosing Angiogenic Tumor
• Sclerosing Endothelial Tumor
• Sclerosing Epithelioid Angiosarcoma
• Sclerosing Interstitial Vascular Sarcoma
• Sclerosing Stromal Cell Tumor
• SDF-1α
• SDGF
• Sdi1
• Second Malignant Neoplasm SMN
• Second Primary Cancer SPC
• Second Primary Cancers
• Second Primary Malignancy SPM
• Second Primary Tumors
• Secondary Metabolites
• Secondary Tumor
• Secretagogues
• γ-Secretase
• Secreted Phosphoprotein 1
• Secreted Protein Acidic and Rich in Cysteine
• Securin
• “Seed and Soil” Theory of Metastasis
• SEL-12
• Selective Effect
• Selective Serotonin Reuptake Inhibitors
• Selenium
• SELEX
• SEMA
• Semanová II Syndrome
• Semaphorin
• Semaphorin Receptors
• Semaxanib (SU5416)
• Seminoma
• Seminomatous Germ Cell Tumor
• Senescence and Immortalization
• Senescence-Associated Chronic Inflammation
• Senile Involution
• Sentinel Lymph Node
• Sentinel Node
• SEREX
• Serine Elastase
• Serine Protease Inhibitor-Like Domain
• Serine Proteases (Type II) Spanning the Plasma Membrane
• Serine-Threonine Kinase Receptor-Associated Protein
• Sertoli-Leydig Cell Tumor
• Serum Biomarkers
• Seven in Absentia Homologue
• Severe Hypoxia
• Sex Cord-Stromal Tumors – Granulosa Cell Tumors
• Sex Cord-Stromal Tumors with Annular Tubules
• Sezary Syndrome
• SH2/SH3 Domains
• SH2/Src Homology 3
• SH3 Domains
• SH3p17
• SH3p18
• SH3P9
• Shark Cartilage
• Shedding of Cells
• Short Hairpin RNA
• shRNA
• SIAH
• Sicca Complex
• Sicca Syndrome
• Side Population Cells
• Signal Transducer and Activator of Transcription
• Signal Transducer and Activator of Transcription 3
• Signal Transducers and Activators of Transcription in Oncogenesis
• Signal Transduction
• Signal Transduction Inhibitor-571
• Silent Mating Type Information Regulation 2 Homolog 1
• SIMA135 (Subtractive Immunization M(+)HEp3 Associated 135 kDa Protein)
• Simian Virus 40
• Single-Cell Gel Electrophoresis Assay
• Single-Cell Microgel Electrophoresis Assay
• Single-Chain Fv Dimer
• SIR2L1
• SiRNA
• siRNA
• Sirolimus
• SIRT1
• Sirtuin 1
• Site-Specific Drug Delivery
• Sivelestat
• Sjögren Syndrome
• Skeletal Complications (Skeletal-Related Events)
• Skeletal Metastasis
• Skeletal Secondary Tumors
• Skeletrophin
• SKI390
• Skin Cancer
• Skin Carcinogenesis
• Skinny Needle
• Skipper-Schabel Model
• Skipper-Schabel-Wilcox Model
• Skp2
• SL-1
• Slit
• Sloughing of Cells
• SM-5887
• SMA- and MAD-Related Protein 4
• Smad Proteins in TGF-Beta Signaling
• SMAD4
• Small Cell and Large Cell Neuroendocrine Carcinomas (NEC) at the Highly Aggressive Pole of the Spectrum of NENs
• Small Cell Lung Cancer
• Small Cell Neuroendocrine Carcinoma
• Small Cleaved Cell Lymphoma
• Small GTP-Binding Proteins
• Small Interfering RNA
• Small Molecule Drugs
• Small Molecule Screens
• Small Round Cell Tumor
• SMARCB1
• SMAX1
• SMR
• Snail Transcription Factors
• SOCS
• Sodium Chloride
• Soft Tissue Sarcoma
• Solar Light-Induced Cancer
• Soluble ATP-Dependent Non-Lysosomal Proteolytic System
• Soluble Mesothelin-Related Proteins
• Somatic Recombination of V, D, and J Segments
• Somatic Stem Cells
• Somatocrinin
• Somatoliberin
• Somites
• Sonochemotherapy
• Sonodynamic Therapy
• Sorafenib
• Sorafenib (Nexavar)
• Sorafenib [INN]
• Sorafenibum
• Soy Phytoestrogen
• SPARC
• Spasmolytic Polypeptide SP/TFF2
• SPB
• SPC1
• Specific Immunotherapy for Melanoma
• Spectral Karyotyping
• Sphacelus
• S-Phase Damage-Sensing Checkpoints
• S-Phase-Kinase-Associated Protein 2
• Sphingolipid Metabolism
• Spinal and Bulber Muscular Atrophy (SBMA)
• Spindle Assembly Checkpoint
• Spindle Pole Body
• Spinesin (TMPRSS5)
• Spleen Tyrosine Kinase
• Sprouty
• Spry
• Squamous Cell Carcinoma
• Src
• Src Homology 2
• SRC-1: NCOA1
• SRC-2: NCOA2
• SRC-3
• SRC-3: NCOA3
• Src8
• SSRIs
• Stage IA–C Ovarian Cancer
• Staging of Tumors
• STARD12
• START Domain-Containing Protein
• STAT
• STAT3
• Staurosporine
• Steel Ligand Receptor
• Stefins
• Stem Cell Factor
• Stem Cell Imaging
• Stem Cell Markers
• Stem Cell Mobilization
• Stem Cell Plasticity
• Stem Cell Telomeres
• Stem-Like Cancer Cells
• Steroid Receptor Coactivator-3
• Steroid Receptor Coactivators
• Steroid Receptor Coactivators (SRCs): Nuclear Receptor Coactivators (NCOAs)
• Steroid Sulfatase
• Steroid Sulfohydrolase
• Steroid Tumor
• Steroid X Receptor (SXR)
• Steryl Sulfohydrolase
• STI571
• STI-571
• Sticker Sarcoma
• Stivarga
• STK12
• STK13
• STK15
• STK5
• STK6
• STK7
• STMY1
• Stomach Cancer
• STR1
• STRAP
• Stress
• Stress Response
• Stress-Activated Protein Kinase
• Stress-Induced Bystander Effect
• Stroma
• Stromagenesis
• Stromal Cell Response
• Stromal Progression
• Stromatogenesis
• Stromelysin-1
• Structural Biology
• Structural Vascular Stabilization
• STS
• Subarachnoidal Spread
• Subependymal Giant Cell Astrocytoma
• Suberoylanilide Hydroxamic Acid
• Substrate Channeling
• Subtype AML-M7
• Suicide Gene Therapy
• Sulfated Glycoprotein-2 (SGP-2)
• Sulfokinases
• Sulforaphane
• Sulfotransferases
• Sunitinib (Sutent)
• Sunlight-Induced Cancer
• Supervised Classification
• Supervised Learning
• Supportive Care
• Suppressive T Cells
• Suppressor of Invasion, Metastasis, and Angiogenesis
• Suppressors of Cytokine Signaling
• Surface Molecules
• Surface Plasmon Resonance
• Surgical Pathology
• Surgical Trauma and Cancer Recurrence
• Surrogate Endpoint
• Surrogate Endpoint Biomarker
• Surrogate Outcome
• Survivin
• Susceptibility Loci
• SV40
• SWI/SNF-Related, Matrix-Associated, Actin-Dependent Regulator of Chromatin Subfamily b, Member 1
• Syk
• Syk Tyrosine Kinase
• SYLD (syld709613 Protein)
• Synovial Sarcoma
• Synthetic Cannabinoids
• Synuclein
• Systemic Antibody-Directed Radionuclide Therapy
• Systemic Spread of Cancer
• Systemic Therapy
• T
• T-Cell Response
• Tachykinins
• Tamoxifen
• Tankyrases
• Targeted Drug Delivery
• Targeting Cancer Stem Cells
• TAT Protein of HIV
• Taxol
• Taxotere
• TCL1
• Technical Knockout
• Telomerase
• Temozolomide
• Temsirolimus
• Tenascin-C
• Tensional Homeostasis
• Testicular Cancer
• Testicular Germ Cell Tumors
• Theranostics
• Thiazolidin
• Thioredoxin System
• Three-Dimensional Culture
• Three-Dimensional Tissue Cultures
• Thrombospondin
• Thymidine Phosphorylase
• Thymoma
• Thyroid Cancer Treatment
• Thyroid Carcinogenesis
• Tiam1
• Tight Junction
• Time of Flight
• Time-Resolved Fluorescence Resonance Energy Transfer Technology in Drug Discovery
• Tissue Inhibitors of Metalloproteinases
• Tissue Stem Cells
• TLR4
• TMPRSS2/ERG Fusions
• TNF-Related Apoptosis-Inducing Ligand
• TNF-α in HIV Infection
• Tobacco Carcinogenesis
• Tobacco-Related Cancers
• Toll-Like Receptors
• Tongue Cancer
• Topoisomerases
• Toxicogenomics
• Toxicological Carcinogenesis
• TP53
• Trabectedin
• TRAIL Receptor Antibodies
• Transcoelomic Metastasis
• Transduction of Oncogenes
• Transforming Growth Factor-Beta
• Transgenic Mouse
• Transglutaminase-2
• Transitional Cell Carcinoma
• Translesion DNA Polymerases
• Transplacental Carcinogenesis
• Trastuzumab
• Trefoil Factors
• Triple-Negative Breast Cancer
• Trophectoderm
• Tuberous Sclerosis Complex
• Tumor Antigens
• Tumor Cell-Induced Platelet Aggregation
• Tumor Microenvironment
• Tumor Necrosis Factor
• Tumor Suppression
• Tumor Suppressor Genes
• Tumor-Associated Macrophages
• Tumor–Endothelial Cross-Talk
• Tunicamycin
• Turcot Syndrome
• Tyrosine Kinase Inhibitors
• U
• Ubiquitin Ligase SCF-Skp2
• Ubiquitination
• UCN-01 Anticancer Drug
• Ultrasound Microimaging
• Uncertain or Unknown Histogenesis Tumors
• Unfolded Protein Response and Cancer
• Uranium Miners
• Urokinase-Type Plasminogen Activator
• Urothelial Carcinoma
• Urothelial Carcinoma, Clinical Oncology
• Uterine Leiomyoma
• Uterine Leiomyoma, Clinical Oncology
• UTX
• UV Radiation
• Uveal Melanoma
• V
• V(D)J Recombination
• Valproic Acid
• Vanadium
• Vascular Disrupting Agents
• Vascular Endothelial Growth Factor
• Vascular Stabilization
• Vascular Targeting Agents
• Vasculogenic Mimicry
• Vasopressin
• Villi
• Viral Oncology Epigenetics
• Viral Vector-Mediated Gene Transfer
• Virology
• Virotherapy
• Vitamin D
• Von Hippel-Lindau Disease
• Von Hippel-Lindau Tumor Suppressor Gene
• Vorinostat
• W
• Warburg Effect
• Wilms’ Tumor
• WIPI
• Withaferin A
• Wnt Signaling
• WWOX
• X
• Xenobiotics
• Xeroderma Pigmentosum
• XIAP
• Xiphophorus
• Z
• Z-Factor
• Zoledronic Acid
• Zonula Occludens Protein-1